DeutschNewstral
Article
bizjournals.com on 2015-04-24 15:27
Seattle Genetics' exec: Here's how to stay an independent biotech in Seattle
Related news
Seattle Genetics buys biotech factory in Bothellseattletimes.com- Seattle Genetics operations chief resigns to lead stealthy Seattle biotechbizjournals.com
- Seattle Genetics scoops up local biotech Cascadian Therapeuticsseattletimes.com
- Seattle Genetics discloses pay for executives at the Puget Sound region's biggest biotechbizjournals.com
- Biotech update: Seattle Genetics grows, medical device company disappearsbizjournals.com
- Seattle Genetics will buy Cascadian Therapeutics in local biotech dealseattletimes.com
- Analysts predict loss ahead for Seattle Geneticsbizjournals.com
- Apple, PerkinElmer rise; EQT, Seattle Genetics fallseattletimes.com
Seattle Genetics takes a new identitySeattle Times- Biotech leaders sound off on how to create anchor companies, stable ecosystem in Seattlebizjournals.com
- Seattle Genetics drug wins FDA approval, could boost biotech's revenuebizjournals.com
- Seattle Genetics reports $21M loss but beats analysts' estimatesbizjournals.com
- Seattle Genetics pays Cambridge startup $25M to grow immunotherapy portfoliobizjournals.com
- Growing Seattle Genetics tests cancer therapy for treatment of lupusbizjournals.com
Seattle Genetics plans to expand and add 200 workersEverett Herald- Premium investment: Independent Health backs a biotech startup out of Seattlebizjournals.com
- Biotech roundup: How many drugs has Seattle developed?bizjournals.com
- Here's why one biotech, courted by San Diego, decided to stay in Seattlebizjournals.com
- Seattle biotech stalwart ZymoGenetics prepares for year-end closureSeattle Times
- MShares of Seattle Genetics jump as Merck makes up to $4.2 billion investmentmarketwatch.com